tacrolimus monohydrate - search results

New Zealand - English - Medsafe (Medicines Safety Authority)

tacrolimus sandoz

sandoz new zealand limited - tacrolimus monohydrate 1.022mg equivalent to 1 mg tacrolimus - capsule - 1 mg - active: tacrolimus monohydrate 1.022mg equivalent to 1 mg tacrolimus excipient: croscarmellose sodium hypromellose capsugel white/brown g4ics000510 lactose monohydrate magnesium stearate - primary immunosuppression in liver, kidney, pancreas, kidney-pancreas, lung or heart allograft recipients and rescue use in liver, kidney or other solid organ (heart, lung, pancreas or kidneys) transplantation, that has either failed conventional immunosuppressive agents, or where such agents are producing intolerable side effects.

New Zealand - English - Medsafe (Medicines Safety Authority)

tacrolimus sandoz

sandoz new zealand limited - tacrolimus monohydrate 5.11mg equivalent to 5 mg tacrolimus - capsule - 5 mg - active: tacrolimus monohydrate 5.11mg equivalent to 5 mg tacrolimus excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate opaque orange g3ics000767 - primary immunosuppression in liver, kidney, pancreas, kidney-pancreas, lung or heart allograft recipients and rescue use in liver, kidney or other solid organ (heart, lung, pancreas or kidneys) transplantation, that has either failed conventional immunosuppressive agents, or where such agents are producing intolerable side effects.

Ireland - English - HPRA (Health Products Regulatory Authority)

tacrolimus 5 milligram capsules hard

accord healthcare limited - tacrolimus monohydrate - capsules hard - 5 milligram

United States - English - NLM (National Library of Medicine)

tacrolimus ointment

e. fougera & co. a division of fougera pharmaceuticals inc. - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus anhydrous 1 mg in 1 g - tacrolimus ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. tacrolimus ointment is not indicated for children younger than 2 years of age (see boxed warning , warnings and precautions: pediatric use ). tacrolimus ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.

United States - English - NLM (National Library of Medicine)

tacrolimus ointment

padagis israel pharmaceuticals ltd - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus anhydrous 0.3 mg in 1 g - tacrolimus ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. tacrolimus ointment is not indicated for children younger than 2 years of age (see boxed warning, warnings and precautions: pediatric use). tacrolimus ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.